212 related articles for article (PubMed ID: 27045864)
1. A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure.
Xian S; Yang Z; Lee J; Jiang Z; Ye X; Luo L; Jin L; Yang T; Ye S; Lu D
J Ethnopharmacol; 2016 Jun; 186():136-142. PubMed ID: 27045864
[TBL] [Abstract][Full Text] [Related]
2. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
Li X; Zhang J; Huang J; Ma A; Yang J; Li W; Wu Z; Yao C; Zhang Y; Yao W; Zhang B; Gao R;
J Am Coll Cardiol; 2013 Sep; 62(12):1065-1072. PubMed ID: 23747768
[TBL] [Abstract][Full Text] [Related]
3. Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial.
Wang X; Hu D; Dang S; Huang H; Huang CX; Yuan MJ; Tang YH; Zheng QS; Yin F; Zhang S; Zhang BL; Gao RL;
Chin Med J (Engl); 2017 Jul; 130(14):1639-1647. PubMed ID: 28685712
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
Wang J; Shi J; Wei J; Wang J; Gao K; Li X; Chen J; Li S; Zhao H; Wang W
Trials; 2017 Oct; 18(1):468. PubMed ID: 29017565
[TBL] [Abstract][Full Text] [Related]
5. Effect of Shenmai Injection on Long-Term Prognosis of Patients with Chronic Heart Failure: A Multicenter, Large Sample Capacity, Long-Term Follow-Up Retrospective Cohort Study.
Guan H; Dai GH; Gao WL; Zhang T; Sun C; Ren LL; Hou XM; Liu Z
Chin J Integr Med; 2022 Apr; 28(4):312-318. PubMed ID: 34874517
[TBL] [Abstract][Full Text] [Related]
6. The Efficacy and Safety of Xinmailong Injection in Patients with Chronic Heart Failure: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
Xue J; Xu Y; Deng Y; Li F; Liu F; Liu L; Wang X; Wang J; Wang X
J Altern Complement Med; 2019 Aug; 25(8):856-860. PubMed ID: 31295009
[No Abstract] [Full Text] [Related]
7. [Systematic review of efficacy and safety of shenmai injection for chronic heart failure].
Chen HD; Xie YM; Wang LX; Wu JB
Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(18):3650-61. PubMed ID: 25532414
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
Trials; 2015 May; 16():222. PubMed ID: 25994188
[TBL] [Abstract][Full Text] [Related]
9. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
Guo L; Yuan H; Zhang D; Zhang J; Hua Q; Ma X; Chen K
Medicine (Baltimore); 2020 May; 99(21):e20271. PubMed ID: 32481305
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of Chronic Heart Failure Patients with Qi-Yang Deficiency and Blood Stasis Resistance Syndrome by Xnmallong Injection: a Multi-center Randomized Control Study].
Xue JG; Wang XL; Xu Y; Li FC; Liu L; Wang X; Wang JZ; Liu F
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jul; 35(7):796-800. PubMed ID: 26380441
[TBL] [Abstract][Full Text] [Related]
11. Problems with the outcome measures in randomized controlled trials of traditional Chinese medicine in treating chronic heart failure caused by coronary heart disease: a systematic review.
Hu J; Qiu R; Li C; Li M; Dai Q; Chen S; Zhao C; Shang H
BMC Complement Med Ther; 2021 Aug; 21(1):217. PubMed ID: 34465313
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial.
Maulik SK; Wilson V; Seth S; Bhargava B; Dua P; Ramakrishnan S; Katiyar CK
Phytomedicine; 2016 Oct; 23(11):1211-9. PubMed ID: 26988798
[TBL] [Abstract][Full Text] [Related]
13. Shenfu decoction as adjuvant therapy for improving quality of life and hepatic dysfunction in patients with symptomatic chronic heart failure.
Wei H; Wu H; Yu W; Yan X; Zhang X
J Ethnopharmacol; 2015 Jul; 169():347-55. PubMed ID: 25937255
[TBL] [Abstract][Full Text] [Related]
14. Effect of yangxinkang tablets on chronic heart failure: A multi-center randomized double-blind placebo-controlled trial.
Xian SX; Yang ZQ; Ren PH; Ye XH; Ye SL; Wang QH; Wang ZH; Shen SJ; Huang XW
Chin J Integr Med; 2015 Oct; 21(10):733-42. PubMed ID: 25948124
[TBL] [Abstract][Full Text] [Related]
15. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
Trials; 2013 May; 14():138. PubMed ID: 23672353
[TBL] [Abstract][Full Text] [Related]
16. A Phase II, randomized, double-blind, multicenter, based on standard therapy, placebo-controlled study of the efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure.
Gao R; Zhang J; Cheng L; Wu X; Dong W; Yang X; Li T; Liu X; Xu Y; Li X; Zhou M
J Am Coll Cardiol; 2010 May; 55(18):1907-14. PubMed ID: 20430261
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of chronic heart failure by shencao tongmai granule: a multi-centered, double-blinded, randomized, parallel controlled trial].
Wang C; Zhang Y; Gong LH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 May; 32(5):612-5. PubMed ID: 22679719
[TBL] [Abstract][Full Text] [Related]
18. Shenmai injection for chronic pulmonary heart disease: a systematic review and meta-analysis.
Li JS; Wang HF; Li SY; Yu XQ; Wang ZW
J Altern Complement Med; 2011 Jul; 17(7):579-87. PubMed ID: 21711201
[TBL] [Abstract][Full Text] [Related]
19. Western medication plus Traditional Chinese Medicine preparations in patients with chronic heart failure: a prospective, single-blind, randomized, controlled, and multicenter clinical trial.
Wang X; Hou Y; Mao J; Zhang Y; Li Z; Zhao Y; Niu T; Yuan R; Wang Y; Cui J; Shi L; Jia X; Fan R; Lin Q; Shang H; Wang B; Wang H; Zhang B; Cui X; Soh S; Ruan J
J Tradit Chin Med; 2017 Dec; 37(6):756-766. PubMed ID: 32188184
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Shenmai injection on doxorubicin-induced cardiotoxicity via regulation of inflammatory mediators.
Zhang S; You ZQ; Yang L; Li LL; Wu YP; Gu LQ; Xin YF
BMC Complement Altern Med; 2019 Nov; 19(1):317. PubMed ID: 31744501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
